Erik Bechgaard

926 total citations
45 papers, 751 citations indexed

About

Erik Bechgaard is a scholar working on Pharmaceutical Science, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Erik Bechgaard has authored 45 papers receiving a total of 751 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmaceutical Science, 11 papers in Cellular and Molecular Neuroscience and 9 papers in Molecular Biology. Recurrent topics in Erik Bechgaard's work include Advanced Drug Delivery Systems (15 papers), Neuropeptides and Animal Physiology (7 papers) and Analytical Methods in Pharmaceuticals (6 papers). Erik Bechgaard is often cited by papers focused on Advanced Drug Delivery Systems (15 papers), Neuropeptides and Animal Physiology (7 papers) and Analytical Methods in Pharmaceuticals (6 papers). Erik Bechgaard collaborates with scholars based in Denmark, Iceland and Sweden. Erik Bechgaard's co-authors include Sveinbjörn Gizurarson, Morten Bagger, R.K. Hjortkjaer, Jacob Lund, J. A. Christensen, J Fabricius, Erling N. Petersen, Gary P. Martin, Christopher Marriott and Lennart Wetterberg and has published in prestigious journals such as Journal of Controlled Release, Journal of Chromatography A and Analytica Chimica Acta.

In The Last Decade

Erik Bechgaard

42 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Erik Bechgaard Denmark 18 295 144 135 125 114 45 751
Radica Stepanović‐Petrović Serbia 17 85 0.3× 317 2.2× 125 0.9× 204 1.6× 77 0.7× 58 1.0k
Kerry Estes United States 21 139 0.5× 223 1.5× 76 0.6× 120 1.0× 27 0.2× 41 1.0k
Samson Symchowicz United States 22 107 0.4× 268 1.9× 204 1.5× 124 1.0× 49 0.4× 58 1.2k
Seda Özbal Türkiye 19 118 0.4× 214 1.5× 52 0.4× 63 0.5× 33 0.3× 52 994
Çetin Pekçetin Türkiye 19 97 0.3× 157 1.1× 56 0.4× 96 0.8× 15 0.1× 40 795
John A. Labudde United States 9 226 0.8× 137 1.0× 74 0.5× 79 0.6× 63 0.6× 13 772
Gaston Labrecque Canada 20 44 0.1× 152 1.1× 233 1.7× 123 1.0× 39 0.3× 60 1.1k
E S Johnson United Kingdom 17 38 0.1× 249 1.7× 75 0.6× 206 1.6× 60 0.5× 36 774
A. Barkai United States 13 92 0.3× 153 1.1× 44 0.3× 159 1.3× 70 0.6× 32 579
Ranjana Bhandari India 18 79 0.3× 255 1.8× 63 0.5× 77 0.6× 82 0.7× 37 859

Countries citing papers authored by Erik Bechgaard

Since Specialization
Citations

This map shows the geographic impact of Erik Bechgaard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Bechgaard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Bechgaard more than expected).

Fields of papers citing papers by Erik Bechgaard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Erik Bechgaard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Bechgaard. The network helps show where Erik Bechgaard may publish in the future.

Co-authorship network of co-authors of Erik Bechgaard

This figure shows the co-authorship network connecting the top 25 collaborators of Erik Bechgaard. A scholar is included among the top collaborators of Erik Bechgaard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Erik Bechgaard. Erik Bechgaard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bagger, Morten & Erik Bechgaard. (2003). The potential of nasal application for delivery to the central brain—a microdialysis study of fluorescein in rats. European Journal of Pharmaceutical Sciences. 21(2-3). 235–242. 41 indexed citations
2.
Bagger, Morten & Erik Bechgaard. (2003). A microdialysis model to examine nasal drug delivery and olfactory absorption in rats using lidocaine hydrochloride as a model drug. International Journal of Pharmaceutics. 269(2). 311–322. 25 indexed citations
3.
Gizurarson, Sveinbjörn, et al.. (2002). Intranasal bioavailability of diazepam in sheep correlated to rabbit and man. International Journal of Pharmaceutics. 231(1). 67–72. 13 indexed citations
4.
Bechgaard, Erik, et al.. (2001). Solubilization and Stability of Bumetanide in Vehicles for Intranasal Administration, a Pilot Study. Pharmaceutical Development and Technology. 6(2). 145–149. 3 indexed citations
5.
Bagger, Morten, et al.. (2001). Nasal bioavailability of peptide T in rabbits: absorption enhancement by sodium glycocholate and glycofurol. European Journal of Pharmaceutical Sciences. 14(1). 69–74. 29 indexed citations
6.
Bagger, Morten, et al.. (2001). Intranasal bioavailability of buprenorphine in rabbit correlated to sheep and man. International Journal of Pharmaceutics. 217(1-2). 121–126. 18 indexed citations
7.
Gizurarson, Sveinbjörn, et al.. (2001). Electroencephalographic effects and serum concentrations after intranasal and intravenous administration of diazepam to healthy volunteers. British Journal of Clinical Pharmacology. 52(5). 521–527. 28 indexed citations
8.
Gizurarson, Sveinbjörn, et al.. (2000). Intranasal absorption of buprenorphine—in vivo bioavailability study in sheep. International Journal of Pharmaceutics. 205(1-2). 159–163. 22 indexed citations
9.
Bechgaard, Erik, et al.. (2000). Intranasal administration of different liquid formulations of bumetanide to rabbits. International Journal of Pharmaceutics. 204(1-2). 35–41. 9 indexed citations
10.
Gizurarson, Sveinbjörn, et al.. (1999). Intranasal Administration of Diazepam Aiming at the Treatment of Acute Seizures: Clinical Trials in Healthy Volunteers.. Biological and Pharmaceutical Bulletin. 22(4). 425–427. 29 indexed citations
11.
Bechgaard, Erik. (1999). Intranasal absorption of melatonin in vivo bioavailability study. International Journal of Pharmaceutics. 182(1). 1–5. 23 indexed citations
12.
Bechgaard, Erik, et al.. (1998). High-performance liquid chromatographic analysis of melatonin in human plasma and rabbit serum with on-line column enrichment. Journal of Chromatography B Biomedical Sciences and Applications. 712(1-2). 177–181. 16 indexed citations
13.
Bechgaard, Erik, et al.. (1997). Solubilization of Various Benzodiazepines for Intranasal Administration, a Pilot Study. Pharmaceutical Development and Technology. 2(3). 293–296. 9 indexed citations
14.
Bechgaard, Erik, et al.. (1997). High-performance liquid chromatographic analysis of Peptide T in rabbit plasma with on-line column enrichment. Journal of Chromatography B Biomedical Sciences and Applications. 693(1). 237–240. 7 indexed citations
15.
Larsen, Fin Stolze, et al.. (1995). Intranasal absorption of different aqueous formulations of angiopeptin: In vivo bioavailability study. International Journal of Pharmaceutics. 113(1). 83–87. 1 indexed citations
16.
Gizurarson, Sveinbjörn & Erik Bechgaard. (1991). Study of Nasal Enzyme Activity towards Insulin. In Vitro.. Chemical and Pharmaceutical Bulletin. 39(8). 2155–2157. 25 indexed citations
17.
Gizurarson, Sveinbjörn & Erik Bechgaard. (1991). Intranasal administration of insulin to humans. Diabetes Research and Clinical Practice. 12(2). 71–84. 43 indexed citations
18.
Gizurarson, Sveinbjörn & Erik Bechgaard. (1991). Insulin-Carrying Microspheres, in Vitro Studies.. Chemical and Pharmaceutical Bulletin. 39(7). 1892–1893.
19.
Bechgaard, Erik. (1985). Acnegenicity testing in rabbits. An objective quantification method. Acta Dermato Venereologica. 65(4). 282–286.
20.
Petersen, Erling N., et al.. (1978). Potent depletion of 5HT from monkey whole bloob by a new 5HT uptake inhibitor, paroxetine (FG 7051). European Journal of Pharmacology. 52(1). 115–119. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Radica Stepanović‐Petrović Breakdown of academic impact, for papers by Kerry Estes Breakdown of academic impact, for papers by Samson Symchowicz Breakdown of academic impact, for papers by Seda Özbal Breakdown of academic impact, for papers by Çetin Pekçetin Breakdown of academic impact, for papers by John A. Labudde Breakdown of academic impact, for papers by Gaston Labrecque Breakdown of academic impact, for papers by E S Johnson Breakdown of academic impact, for papers by A. Barkai Breakdown of academic impact, for papers by Ranjana Bhandari
Rankless by CCL
2026